Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

Despite substantial health benefits, two GLP-1 receptor agonists weren't cost-effective at their current prices, according to ...

Source: Getty Images At the 2024 Neuroscience Education Institute Scientific Congress, researchers Maxwell Price and Richard Price, MD presented on the promising effects of extended-release ...

4 Cancer Research UK Health Behaviour Research Centre, University College London, London, UK Background Varenicline and bupropion are effective smoking cessation treatments, but there are concerns ...

Compared with placebo, extended-release naltrexone-bupropion combination therapy reduced total fat mass and improved the lean-to-fat mass ratio in individuals with obesity or overweight and ...

In the latest research, scientists from Canada tracked nearly 3,000 Americans who used either semaglutide, the active drug in ...

However, some studies have suggested positive results in comparison to common ADHD medications and a placebo (substance without the medication). In three head-to-head (comparative) studies, bupropion ...

Genetic testing is transforming depression treatment by tailoring antidepressants to your DNA for better results and fewer side effects.

Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good thing? And is depression weight loss even a thing in the first place?

The process starts with visual, mental or physical sexual stimulation, triggering the brain to release dopamine, which ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...